News

EMA recommends marketing authorization to Cordex Biologics’ new stem cell therapy, Zemcelpro to treat patients with blood cancers: Amsterdam, The Netherlands Monday, June 23, 20 ...
The EC has approved argenx’s Vyvgart (efgartigimod alfa) 1000mg as a single agent for subcutaneous injection to treat CIDP.